Total Payments
$34,621
2024 Payments
$2,426
Companies
67
Transactions
975
Medicare Patients
8,504
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$32,683 (94.4%)
Consulting$1,840 (5.3%)
Education$98.53 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $32,683 | 962 | 94.4% |
| Consulting Fee | $1,840 | 1 | 5.3% |
| Education | $98.53 | 12 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $4,705 | 106 | $0 (2024) |
| Novo Nordisk Inc | $4,215 | 150 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $2,968 | 35 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,615 | 49 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,509 | 65 | $0 (2023) |
| ABBVIE INC. | $2,434 | 67 | $0 (2024) |
| Lilly USA, LLC | $2,409 | 95 | $0 (2024) |
| Amgen Inc. | $1,314 | 38 | $0 (2024) |
| Amarin Pharma Inc. | $1,246 | 42 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $951.17 | 30 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,426 | 83 | AstraZeneca Pharmaceuticals LP ($608.83) |
| 2023 | $4,836 | 146 | AstraZeneca Pharmaceuticals LP ($826.62) |
| 2022 | $6,502 | 155 | Bayer HealthCare Pharmaceuticals Inc. ($2,196) |
| 2021 | $5,245 | 157 | AbbVie Inc. ($902.48) |
| 2020 | $2,361 | 108 | Lilly USA, LLC ($348.63) |
| 2019 | $3,834 | 102 | Janssen Pharmaceuticals, Inc ($644.81) |
| 2018 | $3,961 | 102 | Novo Nordisk Inc ($905.00) |
| 2017 | $5,455 | 122 | AstraZeneca Pharmaceuticals LP ($749.83) |
All Payment Transactions
975 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Oncology | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Diabetes Care | ||||||
| 11/12/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Cardiovascular Diseases | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Insomnia | ||||||
| 10/24/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $19.89 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: Biological | ||||||
| 10/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.86 | General |
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Gastroenterology | ||||||
| 09/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $113.85 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: Hematology | ||||||
| 09/24/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Endocrinology | ||||||
| 09/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: PAIN | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $32.28 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,424 | 2,347 | $442,865 | $169,109 |
| 2022 | 20 | 2,376 | 5,393 | $849,404 | $325,234 |
| 2021 | 21 | 2,562 | 5,953 | $941,296 | $360,893 |
| 2020 | 22 | 2,142 | 3,531 | $582,322 | $222,508 |
Total Patients
8,504
Total Services
17,224
Medicare Billing
$1.1M
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 348 | 901 | $236,229 | $84,749 | 35.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 168 | 168 | $44,653 | $21,959 | 49.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 329 | $61,187 | $21,636 | 35.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 157 | 159 | $27,203 | $11,932 | 43.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 54 | 156 | $15,567 | $5,624 | 36.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 21 | $11,942 | $4,692 | 39.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 54 | 104 | $10,214 | $3,614 | 35.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 168 | 168 | $6,384 | $3,111 | 48.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 162 | 162 | $6,157 | $3,000 | 48.7% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 42 | 73 | $5,825 | $2,202 | 37.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $6,222 | $2,108 | 33.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,749 | $1,850 | 49.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 25 | $3,225 | $1,266 | 39.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 29 | $2,813 | $1,103 | 39.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 23 | $1,495 | $260.92 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 478 | 1,247 | $332,940 | $118,743 | 35.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 284 | 284 | $77,248 | $37,964 | 49.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 106 | 796 | $81,991 | $31,263 | 38.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 103 | 648 | $72,590 | $27,382 | 37.7% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 98 | 794 | $66,688 | $25,901 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 189 | 289 | $54,910 | $19,304 | 35.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 285 | 286 | $50,622 | $18,589 | 36.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 30 | 227 | $29,964 | $11,728 | 39.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 36 | 42 | $24,276 | $9,466 | 39.0% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 307 | 307 | $11,666 | $5,823 | 49.9% |
About Dr. Brian Moraes, DO
Dr. Brian Moraes, DO is a Internal Medicine healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417908823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Moraes, DO has received a total of $34,621 in payments from pharmaceutical and medical device companies, with $2,426 received in 2024. These payments were reported across 975 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($32,683).
As a Medicare-enrolled provider, Moraes has provided services to 8,504 Medicare beneficiaries, totaling 17,224 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Boca Raton, FL
- Active Since 05/12/2006
- Last Updated 04/22/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417908823
Products in Payments
- Kerendia (Drug) $2,955
- JARDIANCE (Drug) $2,460
- FARXIGA (Drug) $2,408
- Ozempic (Drug) $1,686
- XARELTO (Drug) $1,533
- Vascepa (Drug) $1,246
- TRULICITY (Drug) $1,142
- VRAYLAR (Drug) $993.29
- BEVESPI AEROSPHERE (Drug) $835.72
- UBRELVY (Drug) $821.84
- BREZTRI (Drug) $778.92
- INVOKANA (Drug) $731.81
- Victoza (Drug) $691.80
- RYBELSUS (Drug) $564.76
- Repatha (Biological) $494.68
- SOLIQUA (Drug) $465.27
- FFRct (Device) $460.53
- ELIQUIS (Drug) $446.88
- XIFAXAN (Drug) $441.86
- Prolia (Biological) $407.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Boca Raton
Dr. Stephen Milan, M.d, M.D
Internal Medicine — Payments: $86,912
Internal Medicine $86,912
Ricardo Marques
Internal Medicine — Payments: $49,089
Internal Medicine $49,089
Dr. Heather Johnson, M.d, M.D
Internal Medicine — Payments: $29,015
Internal Medicine $29,015
Michael Cammarata, Md, MD
Internal Medicine — Payments: $17,985
Internal Medicine $17,985
Dr. Eli Levine, M.d, M.D
Internal Medicine — Payments: $15,837
Internal Medicine $15,837
Dr. Gladys Martinez, Do, DO
Internal Medicine — Payments: $14,353
Internal Medicine $14,353